GlassScriptPhysician profile
Jeffrey A Sandler
NPI 1740270313
$22,393.90
in general payments reported to CMS, 2019-2025
13 companies · $71.89 in 2025
The $71.89 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $5,963 · 2021: $3,067 · 2022: $24.26 · 2025: $71.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15,222.94 | 2019-2021 | |
| Abbvie INC. | $5,896.30 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $375.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $272.04 | 2019-2020 | |
| Novo Nordisk INC | $143.55 | 2019-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.56 | 2019-2020 | |
| Dexcom, INC. | $120.60 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $99.56 | 2019-2020 | |
| Insulet Corporation | $51.51 | 2019 | |
| Medtronic Minimed, INC. | $25.06 | 2019-2020 | |
| Horizon Therapeutics Plc | $24.26 | 2022 | |
| Amarin Pharma, INC. | $19.81 | 2019 | |
| Amgen INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Sandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.